40 Stocks Moving In Thursday's Mid-Day Session

Gainers

• Turtle Beach Corporation HEAR surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook.
• ARMO BioSciences, Inc. ARMO shares jumped 66.8 percent to $49.735 after Eli Lilly and Company LLY announced plans to acquire ARMO BioSciences for $50 per share.
• vTv Therapeutics Inc. VTVT gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June.
• Prestige Brands Holdings, Inc. PBH climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings.
• Depomed, Inc. DEPO shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings.
• Everspin Technologies, Inc. MRAM gained 19.8 percent to $8.89 after the company reported strong results for its first quarter.
• Luxfer Holdings PLC LXFR surged 19.8 percent to $17.10 following Q1 results.
• Clean Energy Fuels Corp. CLNE rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million.
• Intelligent Systems Corporation INS gained 17 percent to $7.116.
• Green Dot Corporation GDOT surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings.
• The Chefs' Warehouse, Inc. CHEF climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million.
• Westport Fuel Systems Inc. WPRT rose 14.2 percent to $2.9701.
• Wright Medical Group N.V. WMGI jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings.
• Diplomat Pharmacy, Inc. DPLO gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO.
• Carvana Co. CVNA shares rose 13 percent to $27.97 after reporting upbeat Q1 sales.
• Prothena Corporation plc PRTA gained 12 percent to $15.19 following Q1 results.
• Dynavax Technologies Corporation DVAX rose 11.2 percent to $17.85 after reporting Q1 results.
• DHX Media Ltd. DHXM shares rose 11 percent to $3.275.
• Invitae Corporation NVTA gained 9.5 percent to $6.4848 following Q1 earnings.
• Sunrun Inc. RUN rose 7.5 percent to $10.57 following upbeat quarterly earnings.

Check out these big penny stock gainers and losers

Losers

• Amedica Corporation AMDA shares dipped 49.1 percent to $1.2263 after the company reported pricing of $15,000,000 public offering of units consisting of convertible preferred stock and warrants.
• MDC Partners Inc. MDCA declined 37.6 percent to $4.275 after a first-quarter earnings miss.
• Hudson Technologies Inc. HDSN shares declined 29.3 percent to $2.90 after the company reported downbeat Q1 earnings.
• Stellar Biotechnologies, Inc. SBOT shares dropped 21.4 percent to $4.45.
• Synchronoss Technologies, Inc. SNCR fell 21.2 percent to $7.64.
• Kelly Services, Inc. KELYA declined 21.1 percent to $24.25 after reporting downbeat quarterly earnings.
• Quorum Health Corporation QHC dropped 20.6 percent to $5.95 after reporting Q1 results.
• Infinera Corporation INFN fell 19.2 percent to $9.5061 after reporting Q1 results.
• Puma Biotechnology, Inc. PBYI dropped 18 percent to $53.52 following Q1 results.
• Protagonist Therapeutics, Inc. PTGX shares dropped 16.6 percent to $7.005 following Q1 earnings.
• Amphastar Pharmaceuticals, Inc. AMPH fell 14.9 percent to $16.55 following wider-than-expected quarterly loss.
• Smart Sand, Inc. SND declined 14.7 percent to $6.78 following Q1 results.
• Myomo, Inc. MYO fell 14.3 percent to $3.06 after reporting downbeat quarterly results.
• Nuance Communications, Inc. NUAN fell 13.6 percent to $13.21 after the company posted downbeat Q2 earnings and lowered FY18 organic growth guidance.
• Spark Energy, Inc. SPKE fell 12.9 percent to $10.020 after reporting Q1 results.
• Accelerate Diagnostics, Inc. AXDX shares declined 10.6 percent to $20.075 following Q1 earnings.
• Exelixis, Inc. EXEL fell 9.3 percent to $19.675 after the company disclosed that IMblaze370 Phase 3 pivotal trial of atezolizumab and cobimetinib in patients with heavily pretreated locally advanced or metastatic colorectal cancer did not meet primary endpoint.
• BT Group plc BT fell 8.9 percent to $14.82 after the company reported Q4 results and announced plans to cut 13,000 jobs over the next three years.
• Randgold Resources Limited GOLD shares fell 6.6 percent to $76.90 after reporting Q1 earnings.
• Booking Holdings Inc. BKNG fell 5.3 percent to $2,067.15. Booking Holdings reported stronger-than-expected results for its first quarter. The company sees sales growth of 11.5-15.5 percent year over year and adjusted EBITDA in the range of $1.085 billion-$1.125 billion.